Clinical characteristic of 22 P2RY8-CRLF2–positive relapse cases
| Pt ID . | Sex . | Age at dx, y . | MRD . | Rem, mo . | Rel site . | Source . | Clonal stability of P2RY8-CRLF2 . |
|---|---|---|---|---|---|---|---|
| P2RY8-CRLF2 major clone | |||||||
| 715 | M | 8.90 | IR | 17 | BM | AT | Conserved |
| 737 | M | 9.50 | IR | 25 | BM + CNS | AT | Reduced to minor subclone |
| 1* | F | 2.00 | IR | 33 | BM | DE | Lost |
| 4 | F | 1.40 | IR | 42 | BM | DE | Lost |
| 2* | M | 8.70 | IR | 63 | BM | DE | Conserved |
| 3 | M | 4.60 | LR | 65 | BM | DE | Lost |
| 5* | F | 4.10 | IR | 67 | BM | DE | Conserved |
| 6 | F | 2.70 | LR | 98 | BM | DE | Conserved |
| P2RY8-CRLF2 minor subclone | |||||||
| 775 | M | 13.20 | IR | 11 | BM | AT | Lost |
| 391 | F | 12.70 | IR | 12 | BM | AT | Conserved |
| 814 | F | 4.60 | LR | 18 | BM | AT | Lost |
| 721 | M | 2.50 | IR | 20 | testis | AT | Conserved |
| 778 | M | 4.20 | IR | 20 | BM | AT | Lost |
| 810 | M | 4.90 | IR | 28 | BM + CNS | AT | Lost |
| 579 | M | 1.30 | IR | 35 | BM | AT | Lost |
| 460 | F | 5.70 | IR | 36 | BM | AT | Lost |
| 571 | M | 9.20 | IR | 44 | BM | AT | Lost |
| 456 | M | 12.00 | IR | 48 | BM | AT | Conserved |
| 545 | M | 4.70 | LR | 55 | BM | AT | Lost |
| 564* | M | 8.25 | LR | 55 | BM | AT | Different minor subclone |
| 417* | F | 9.75 | 60 | BM | AT | Conserved | |
| 243* | F | 10.40 | IR | 71 | BM | AT | Conserved |
| Pt ID . | Sex . | Age at dx, y . | MRD . | Rem, mo . | Rel site . | Source . | Clonal stability of P2RY8-CRLF2 . |
|---|---|---|---|---|---|---|---|
| P2RY8-CRLF2 major clone | |||||||
| 715 | M | 8.90 | IR | 17 | BM | AT | Conserved |
| 737 | M | 9.50 | IR | 25 | BM + CNS | AT | Reduced to minor subclone |
| 1* | F | 2.00 | IR | 33 | BM | DE | Lost |
| 4 | F | 1.40 | IR | 42 | BM | DE | Lost |
| 2* | M | 8.70 | IR | 63 | BM | DE | Conserved |
| 3 | M | 4.60 | LR | 65 | BM | DE | Lost |
| 5* | F | 4.10 | IR | 67 | BM | DE | Conserved |
| 6 | F | 2.70 | LR | 98 | BM | DE | Conserved |
| P2RY8-CRLF2 minor subclone | |||||||
| 775 | M | 13.20 | IR | 11 | BM | AT | Lost |
| 391 | F | 12.70 | IR | 12 | BM | AT | Conserved |
| 814 | F | 4.60 | LR | 18 | BM | AT | Lost |
| 721 | M | 2.50 | IR | 20 | testis | AT | Conserved |
| 778 | M | 4.20 | IR | 20 | BM | AT | Lost |
| 810 | M | 4.90 | IR | 28 | BM + CNS | AT | Lost |
| 579 | M | 1.30 | IR | 35 | BM | AT | Lost |
| 460 | F | 5.70 | IR | 36 | BM | AT | Lost |
| 571 | M | 9.20 | IR | 44 | BM | AT | Lost |
| 456 | M | 12.00 | IR | 48 | BM | AT | Conserved |
| 545 | M | 4.70 | LR | 55 | BM | AT | Lost |
| 564* | M | 8.25 | LR | 55 | BM | AT | Different minor subclone |
| 417* | F | 9.75 | 60 | BM | AT | Conserved | |
| 243* | F | 10.40 | IR | 71 | BM | AT | Conserved |
Pt indicates patient; dx, initial diagnosis; MRD, minimal residual disease risk classification; Rem, remission; Rel, relapse; BM, bone marrow; and CNS, central nervous system.
Down syndrome.